These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 27229685

  • 1. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
    Alten R, Bingham CO, Cohen SB, Curtis JR, Kelly S, Wong D, Genovese MC.
    BMC Musculoskelet Disord; 2016 May 26; 17():231. PubMed ID: 27229685
    [Abstract] [Full Text] [Related]

  • 2. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
    Kaine JL, Kivitz AJ, Birbara C, Luo AY.
    J Rheumatol; 2007 Feb 26; 34(2):272-9. PubMed ID: 17304653
    [Abstract] [Full Text] [Related]

  • 3. Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.
    Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Kozuru H, Jiuchi Y, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Takahi K, Yoshizawa S, Kawabe Y, Suenaga Y, Ozawa T, Hamada N, Komiya Y, Matsui T, Furukawa H, Oishi K.
    Arthritis Res Ther; 2015 Dec 10; 17():357. PubMed ID: 26653668
    [Abstract] [Full Text] [Related]

  • 4. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
    Kivitz AJ, Schechtman J, Texter M, Fichtner A, de Longueville M, Chartash EK.
    J Rheumatol; 2014 Apr 10; 41(4):648-57. PubMed ID: 24584918
    [Abstract] [Full Text] [Related]

  • 5. Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients.
    Nived P, Jönsson G, Settergren B, Einarsson J, Olofsson T, Jørgensen CS, Skattum L, Kapetanovic MC.
    Arthritis Res Ther; 2020 Feb 22; 22(1):36. PubMed ID: 32087733
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study.
    Marantos T, Kyriazopoulou E, Angelakis E, Kitsos D, Chondrogianni M, Mpizta G, Papadopoulos A, Giannopoulos S, Voumvourakis K, Tsiodras S.
    Vaccine; 2024 Sep 17; 42(22):126001. PubMed ID: 38796324
    [Abstract] [Full Text] [Related]

  • 7. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
    Subesinghe S, Bechman K, Rutherford AI, Goldblatt D, Galloway JB.
    J Rheumatol; 2018 Jun 17; 45(6):733-744. PubMed ID: 29545454
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.
    Nakashima K, Aoshima M, Ohfuji S, Yamawaki S, Nemoto M, Hasegawa S, Noma S, Misawa M, Hosokawa N, Yaegashi M, Otsuka Y.
    Hum Vaccin Immunother; 2018 Jun 17; 14(8):1923-1930. PubMed ID: 29561248
    [Abstract] [Full Text] [Related]

  • 9. The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis.
    Winthrop KL, Silverfield J, Racewicz A, Neal J, Lee EB, Hrycaj P, Gomez-Reino J, Soma K, Mebus C, Wilkinson B, Hodge J, Fan H, Wang T, Bingham CO.
    Ann Rheum Dis; 2016 Apr 17; 75(4):687-95. PubMed ID: 25795907
    [Abstract] [Full Text] [Related]

  • 10. Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab.
    Tsuru T, Terao K, Murakami M, Matsutani T, Suzaki M, Amamoto T, Nakashima H, Akiyama A, Nishimoto N.
    Mod Rheumatol; 2014 May 17; 24(3):511-6. PubMed ID: 24252023
    [Abstract] [Full Text] [Related]

  • 11. Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
    Crnkic Kapetanovic M, Saxne T, Jönsson G, Truedsson L, Geborek P.
    Arthritis Res Ther; 2013 Oct 30; 15(5):R171. PubMed ID: 24286269
    [Abstract] [Full Text] [Related]

  • 12. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.
    Crnkic Kapetanovic M, Saxne T, Truedsson L, Geborek P.
    Arthritis Res Ther; 2013 Jan 04; 15(1):R1. PubMed ID: 23286772
    [Abstract] [Full Text] [Related]

  • 13. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
    Kapetanovic MC, Kristensen LE, Saxne T, Aktas T, Mörner A, Geborek P.
    Arthritis Res Ther; 2014 Jan 02; 16(1):R2. PubMed ID: 24383620
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).
    Nguyen M, Lindegaard H, Hendricks O, Friis-Møller N.
    Scand J Rheumatol; 2017 Nov 02; 46(6):446-453. PubMed ID: 28145151
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults.
    Song JY, Cheong HJ, Tsai TF, Chang HA, Choi MJ, Jeon JH, Kang SH, Jeong EJ, Noh JY, Kim WJ.
    Vaccine; 2015 Aug 26; 33(36):4647-52. PubMed ID: 25980426
    [Abstract] [Full Text] [Related]

  • 16. Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs.
    Kapetanovic MC, Roseman C, Jönsson G, Truedsson L.
    Clin Rheumatol; 2011 Dec 26; 30(12):1555-61. PubMed ID: 21956234
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC, Nagel J, Nordström I, Saxne T, Geborek P, Rudin A.
    Vaccine; 2017 Feb 07; 35(6):903-908. PubMed ID: 28081972
    [Abstract] [Full Text] [Related]

  • 18. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.
    Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Sugiyama T, Kawabe Y, Katayama M, Suenaga Y, Okamoto A, Ohshima H, Okada Y, Ichikawa K, Yoshizawa S, Kawakami K, Matsui T, Furukawa H, Oishi K.
    Arthritis Res Ther; 2015 Jun 03; 17(1):149. PubMed ID: 26036592
    [Abstract] [Full Text] [Related]

  • 19. Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis.
    Jain VK, Bhashini N, Balajee LK, Sistla S, Parija SC, Negi VS.
    Indian J Med Res; 2017 Apr 03; 145(4):464-470. PubMed ID: 28862177
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept.
    Rákóczi É, Perge B, Végh E, Csomor P, Pusztai A, Szamosi S, Bodnár N, Szántó S, Szücs G, Szekanecz Z.
    Joint Bone Spine; 2016 Dec 03; 83(6):675-679. PubMed ID: 26995488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.